FR2425245A1 - Procede pour la preparation d'une composition injectable d'urokinase - Google Patents

Procede pour la preparation d'une composition injectable d'urokinase

Info

Publication number
FR2425245A1
FR2425245A1 FR7911841A FR7911841A FR2425245A1 FR 2425245 A1 FR2425245 A1 FR 2425245A1 FR 7911841 A FR7911841 A FR 7911841A FR 7911841 A FR7911841 A FR 7911841A FR 2425245 A1 FR2425245 A1 FR 2425245A1
Authority
FR
France
Prior art keywords
urokinase
preparation
injectable composition
lyophilizing
lyophilization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7911841A
Other languages
English (en)
Other versions
FR2425245B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Chemical Co Ltd
Original Assignee
Sumitomo Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co Ltd filed Critical Sumitomo Chemical Co Ltd
Publication of FR2425245A1 publication Critical patent/FR2425245A1/fr
Application granted granted Critical
Publication of FR2425245B1 publication Critical patent/FR2425245B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

ON PREPARE UNE COMPOSITION INJECTABLE D'UROKINASE STABLE PAR LA LYOPHILISATION DE L'UROKINASE. LE PROCEDE CONSISTE A LYOPHILISER UNE SOLUTION AQUEUSE CONTENANT DE L'UROKINASE, DE L'ALBUMINE DE SERUM HUMAIN ET UN OU PLUSIEURS COMPOSES AMINOACIDES CHOISIS PARMI LES AMINOACIDES POLAIRES ET LEURS SELS. L'UROKINASE EST LARGEMENT UTILISEE EN TANT QU'AGENT FIBRINOLYTIQUE DANS LE TRAITEMENT DE MALADIES THROMBOTIQUES; LA PREPARATION DE L'INVENTION CONTENANT DE L'ACIDE GLUTAMIQUE A EGALEMENT UNE PROPRIETE CARACTERISTIQUE EXCELLENTE EN CE QUI CONCERNE SON ACTIVITE THROMBOLYTIQUE.
FR7911841A 1978-05-12 1979-05-10 Procede pour la preparation d'une composition injectable d'urokinase Granted FR2425245A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5682678A JPS54147916A (en) 1978-05-12 1978-05-12 Preparation of urokinase injection

Publications (2)

Publication Number Publication Date
FR2425245A1 true FR2425245A1 (fr) 1979-12-07
FR2425245B1 FR2425245B1 (fr) 1983-03-11

Family

ID=13038173

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7911841A Granted FR2425245A1 (fr) 1978-05-12 1979-05-10 Procede pour la preparation d'une composition injectable d'urokinase

Country Status (10)

Country Link
US (1) US4244943A (fr)
JP (1) JPS54147916A (fr)
CA (1) CA1115206A (fr)
CH (1) CH641046A5 (fr)
DE (1) DE2917899A1 (fr)
DK (1) DK147812B (fr)
FR (1) FR2425245A1 (fr)
GB (1) GB2021412B (fr)
IT (1) IT7949032A0 (fr)
SE (1) SE7904118L (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5813521A (ja) * 1981-07-16 1983-01-26 Green Cross Corp:The ミエロペルオキシダ−ゼの粉末製剤
US4350659A (en) * 1981-07-30 1982-09-21 Corning Glass Works Stabilization of sensitive biologically active intermediate metabolites such as folic acid derivatives
JPS59139323A (ja) * 1983-01-28 1984-08-10 Green Cross Corp:The ウロキナ−ゼ乾燥製剤
SU1128601A1 (ru) * 1983-05-10 1985-07-15 Всесоюзный кардиологический научный центр АМН СССР Урокиназа,иммобилизированна на фибриногене
JPS6051119A (ja) * 1983-08-30 1985-03-22 Green Cross Corp:The ウロキナ−ゼ乾燥製剤
JPS61111684A (ja) * 1984-11-05 1986-05-29 Terumo Corp 精製されたウロキナ−ゼ複合体の製造方法
JPS61124383A (ja) * 1984-11-16 1986-06-12 Unitika Ltd 固定化線維素溶解活性酵素の安定化法
DE3586952T2 (de) * 1985-01-14 1993-07-22 Shiseido Co Ltd Fibrinophiler urokinase-komplex und dessen herstellung.
JPS61238732A (ja) * 1985-04-16 1986-10-24 Green Cross Corp:The ウロキナーゼ前駆体乾燥製剤
KR940003056B1 (ko) * 1985-04-16 1994-04-13 가부시끼가이샤 미도리 쥬우지 우로키나제 전구체를 안정화시키는 방법
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
JP2708749B2 (ja) * 1987-08-10 1998-02-04 エーザイ株式会社 修飾型ｔＰＡ含有注射用組成物
WO1990001334A1 (fr) * 1988-08-05 1990-02-22 Codon Formules d'activateur du plasminogene a base d'aspartate
US4980165A (en) * 1989-01-27 1990-12-25 Genetics Institute, Inc. Pharmaceutical formulations of plasminogen activator proteins
JPH02268681A (ja) * 1989-04-07 1990-11-02 Green Cross Corp:The ウロキナーゼ前駆体の安定化方法及び乾燥製剤
EP0472657B1 (fr) * 1989-05-17 1996-03-13 Research Corporation Technologies, Inc. Procede et composition de traitement de la thrombose chez un mammifere
CA2020148C (fr) * 1989-06-30 1995-07-11 Robert Angelo Mercuri Graphite pur et souple, ultramince
USD403943S (en) 1997-01-24 1999-01-12 Peter James Curry Detachable hand grip tool
EP2236617A1 (fr) 2009-03-31 2010-10-06 Leukocare Ag Procédés de stérilisation de terminal de compositions biofonctionnelles
AU2011247659B2 (en) 2010-04-27 2014-07-24 Scil Technology Gmbh Stable aqueous MIA/CD-RAP formulations
CN104906054B (zh) * 2015-06-15 2017-08-25 武汉人福药业有限责任公司 一种尿激酶冻干剂的制备方法
CN111450052A (zh) * 2020-04-22 2020-07-28 南京南大药业有限责任公司 一种尿激酶注射液制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665076A (fr) * 1963-12-23 1965-12-08
FR2209776A1 (fr) * 1972-12-07 1974-07-05 Ajinomoto Kk

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE665076A (fr) * 1963-12-23 1965-12-08
FR2209776A1 (fr) * 1972-12-07 1974-07-05 Ajinomoto Kk

Also Published As

Publication number Publication date
FR2425245B1 (fr) 1983-03-11
DK147812B (da) 1984-12-17
SE7904118L (sv) 1979-11-13
DE2917899A1 (de) 1979-11-22
CH641046A5 (de) 1984-02-15
JPS54147916A (en) 1979-11-19
CA1115206A (fr) 1981-12-29
IT7949032A0 (it) 1979-05-11
GB2021412A (en) 1979-12-05
US4244943A (en) 1981-01-13
DK195079A (da) 1979-11-13
GB2021412B (en) 1982-08-25

Similar Documents

Publication Publication Date Title
FR2425245A1 (fr) Procede pour la preparation d'une composition injectable d'urokinase
FR2448900A1 (fr) Colle servant a reunir des tissus humains ou d'animaux, procede permettant sa fabrication et applications d'une telle colle
RU93004764A (ru) Амиды сульфамидо- и сульфамидокарбонилпиридин-2-карбоновых кислот, их пиридин-n-оксиды, способ их получения и их применение в качестве лекарственных препаратов
MA21182A1 (fr) Ester 2,3,5,6-tetrafluorobenzylique d'acide (+) 1r-trans-2,2-dimeghyl-3-(2,2 dichlorovinyl) -cyclopropane-carboxylique, son procede de preparation et composition insecticide le contenant.
BG46601A3 (bg) Метод за получаване на авермектинови производни
FR2601876B1 (fr) Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et de l'acide citrique
FR2651497B1 (fr) Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
TNSN94035A1 (fr) Composition veterinaire
GB1441751A (en) Purification of albumin by thermocoagulation
DE04007657T1 (de) Pharmazeutische Zusammensetzung aus fibrinolytischem Mittel
BG49827A3 (bg) Метод за получаване на пречистен биологично активен рекомбинантен човешки колоний стимулиращ фактор
KR840001836A (ko) 생리활성 물질의 제법
FR2333807A1 (fr) Nouveaux derives d'acide fusidique, utiles notamment comme antibacterien en medecine humaine et veterinaire et leur procede de preparation
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
FR2506616A1 (fr) Preparation de gamma-globuline pour injectio n intraveineuse et procede de fabrication, et agent therapeutique ainsi produit
TNSN88073A1 (fr) Nouveaux n - (3-hydroxy-piperidinyl) benzamides, composition pharmaceutique les contenant et procede de preparation de ceux-ci
FR2503149B1 (fr) Esters de mercaptoacyl-carnitines, procede pour leur preparation et leurs utilisations therapeutiques, notamment dans le traitement des intoxications et des brulures et en tant qu'agents mucolytiques
DE69737202T2 (de) Thrombolytische substanzen mit antithrombotische aktivität
GB1160151A (en) Therapeutically Active Metal Chelates of Proteins
GB1404225A (en) Extraction of physiologically active substrates from parathyroid
DE3625090A1 (de) Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
ATE58521T1 (de) Lysinsalz der 4-biphenylessigsaeure und es enthaltende augenheilmittel.
NO904120D0 (no) Protein-inneholdende vandige loesninger.
FR2354097A1 (fr) Composition therapeutique de derives thiazoliques et sa preparation
FR2612774B1 (fr) Compositions cosmetiques et pharmaceutiques, utilisees pour traiter le processus de l'alopecie androgenogenetique, contenant de l'acide azelaique

Legal Events

Date Code Title Description
ST Notification of lapse